Top

Published in:

Open Access 01-12-2020 | COVID-19 | Observational Research

#Covid4Rheum: an analytical twitter study in the time of the COVID-19 pandemic

Authors: Nikolas Ruffer, Johannes Knitza, Martin Krusche

Published in: Rheumatology International | Issue 12/2020

Abstract

Social media services, such as Twitter, offer great potential for a better understanding of rheumatic and musculoskeletal disorders (RMDs) and improved care in the field of rheumatology. This study examined the content and stakeholders associated with the Twitter hashtag #Covid4Rheum during the COVID-19 pandemic. The content analysis shows that Twitter connects stakeholders of the rheumatology community on a global level, reaching millions of users. Specifically, the use of hashtags on Twitter assists digital crowdsourcing projects and scientific collaboration, as exemplified by the COVID-19 Global Rheumatology Alliance registry. Moreover, Twitter facilitates the distribution of scientific content, such as guidelines or publications. Finally, digital data mining enables the identification of hot topics within the field of rheumatology.

Available only for authorised users

Venuturupalli RS, Sufka P, Bhana S (2019) Digital medicine in rheumatology: challenges and opportunities. Rheum Dis Clin North Am 45(1):113–126. https://doi.org/10.1016/j.rdc.2018.09.010CrossRef

Collins C, Campos J, Isabelle A, Bhana S, Jayatilleke A, Sufka P (2018) AB1385l#rheumjc: 3 year analysis of a twitter based rheumatology journal club. Ann Rheum Dis 77(Suppl 2):1777. https://doi.org/10.1136/annrheumdis-2018-eular.3486CrossRef

Negron JB (2019) #EULAR2018: the annual European congress of rheumatology—a twitter hashtag analysis. Rheumatol Int 39(5):893–899. https://doi.org/10.1007/s00296-019-04249-0CrossRef

Studenic P, Ospelt C (2020) OP0339׀ALTMETRIC—does social media impact citation rate in rheumatology journals׀. Ann Rheum Dis 79(Suppl 1):208. https://doi.org/10.1136/annrheumdis-2020-eular.5913CrossRef

Zimba O, Radchenko O, Strilchuk L (2020) Social media for research, education and practice in rheumatology. Rheumatol Int 40(2):183–190. https://doi.org/10.1007/s00296-019-04493-4CrossRef

Pineda C, Perez-Neri I, Sandoval H (2019) Challenges for social media editors in rheumatology journals: an outlook. Clin Rheumatol 38(6):1785–1789. https://doi.org/10.1007/s10067-019-04586-2CrossRef

Pollett S, Rivers C (2020) Social media and the new world of scientific communication during the COVID19 pandemic. Clin Infect Dis. https://doi.org/10.1093/cid/ciaa553CrossRefPubMedCentral

Robinson PC, Yazdany J (2020) The COVID-19 global rheumatology alliance: collecting data in a pandemic. Nat Rev Rheumatol 16(6):293–294. https://doi.org/10.1038/s41584-020-0418-0CrossRef

Krusche M, Burmester GR, Knitza J (2020) Digital crowdsourcing: unleashing its power in rheumatology. Ann Rheum Dis. https://doi.org/10.1136/annrheumdis-2020-217697CrossRefPubMedCentral

10.

Sharma C, Whittle S, Haghighi PD, Burstein F, Sa'adon R, Keen HI (2020) Mining social media data to investigate patient perceptions regarding DMARD pharmacotherapy for rheumatoid arthritis. Ann Rheum Dis. https://doi.org/10.1136/annrheumdis-2020-217333CrossRefPubMedCentral

11.

Yang J, Li Y, Liu Q, Li L, Feng A, Wang T, Zheng S, Xu A, Lyu J (2020) Brief introduction of medical database and data mining technology in big data era. J Evid Based Med 13(1):57–69. https://doi.org/10.1111/jebm.12373CrossRefPubMedCentral

12.

Wallace ZS, Bhana S, Hausmann JS, Robinson PC, Sufka P, Sirotich E, Yazdany J, Grainger R (2020) The rheumatology community responds to the COVID-19 pandemic: the establishment of the COVID-19 global rheumatology alliance. Rheumatology (Oxford) 59(6):1204–1206. https://doi.org/10.1093/rheumatology/keaa191CrossRef

13.

Gianfrancesco M, Hyrich KL, Al-Adely S, Carmona L, Danila MI, Gossec L, Izadi Z, Jacobsohn L, Katz P, Lawson-Tovey S, Mateus EF, Rush S, Schmajuk G, Simard J, Strangfeld A, Trupin L, Wysham KD, Bhana S, Costello W, Grainger R, Hausmann JS, Liew JW, Sirotich E, Sufka P, Wallace ZS, Yazdany J, Machado PM, Robinson PC, Alliance C-GR (2020) Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 global rheumatology alliance physician-reported registry. Ann Rheum Dis 79(7):859–866. https://doi.org/10.1136/annrheumdis-2020-217871CrossRef

14.

Sirotich E, Dillingham S, Grainger R, Hausmann JS, Committee C-GRAS (2020) Capturing patient-reported outcomes during the COVID-19 pandemic: development of the COVID-19 global rheumatology alliance patient experience survey. Arthritis Care Res (Hoboken) 72(7):871–873. https://doi.org/10.1002/acr.24257CrossRef

15.

Sattui SE, Liew JW, Graef ER, Coler-Reilly A, Berenbaum F, Duarte-Garcia A, Harrison C, Konig MF, Korsten P, Putman MS, Robinson PC, Sirotich E, Ugarte-Gil MF, Webb K, Young KJ, Kim AHJ, Sparks JA (2020) Swinging the pendulum: lessons learned from public discourse concerning hydroxychloroquine and COVID-19. Expert Rev Clin Immunol. https://doi.org/10.1080/1744666X.2020.1792778CrossRef

16.

Perniola S, Alivernini S, Varriano V, Paglionico A, Tanti G, Rubortone P, Lanzo L, Melpignano F, Tur C, De Lorenzis E, Peluso G, Capacci A, Gremese E (2020) Telemedicine will not keep us apart in COVID-19 pandemic. Ann Rheum Dis. https://doi.org/10.1136/annrheumdis-2020-218022CrossRef

17.

Kirby T (2020) Rheumatologists rapidly adjust patient care during COVID-19 pandemic. Lancet Rheumatol 2(5):e258. https://doi.org/10.1016/S2665-9913(20)30094-1CrossRefPubMedCentral

18.

Mehra MR, Ruschitzka F, Patel AN (2020) Retraction-Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis. Lancet 395(10240):1820. https://doi.org/10.1016/S0140-6736(20)31324-6CrossRefPubMedCentral

19.

Mehra MR, Desai SS, Kuy S, Henry TD, Patel AN (2020) Cardiovascular disease, drug therapy, and mortality in COVID-19. N Engl J Med 382(25):e102. https://doi.org/10.1056/NEJMoa2007621CrossRefPubMedCentral

20.

Nikiphorou E, Studenic P, Alunno A, Canavan M, Jani M, Berenbaum F (2018) ‘Twitterland’: a brave new world? Ann Rheum Dis 77(8):1245–1246. https://doi.org/10.1136/annrheumdis-2017-212273CrossRef

21.

Luc JGY, Archer MA, Arora RC, Bender EM, Blitz A, Cooke DT, Hlci TN, Kidane B, Ouzounian M, Varghese TK Jr, Antonoff MB (2020) Does tweeting improve citations?. Ann Thorac Surg, One-year results from the TSSMN prospective randomized trial. https://doi.org/10.1016/j.athoracsur.2020.04.065CrossRef

22.

Perez-Perez M, Perez-Rodriguez G, Fdez-Riverola F, Lourenco A (2019) Using twitter to understand the human bowel disease community: exploratory analysis of key topics. J Med Internet Res 21(8):e12610. https://doi.org/10.2196/12610CrossRefPubMedCentral

23.

Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ, Hlh Across SpecialityCollaboration UK (2020) COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 395(10229):1033–1034. https://doi.org/10.1016/S0140-6736(20)30628-0CrossRefPubMedCentral

24.

Yao X, Ye F, Zhang M, Cui C, Huang B, Niu P, Liu X, Zhao L, Dong E, Song C, Zhan S, Lu R, Li H, Tan W, Liu D (2020) In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clin Infect Dis 71(15):732–739. https://doi.org/10.1093/cid/ciaa237CrossRef

25.

Schrezenmeier E, Dorner T (2020) Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology. Nat Rev Rheumatol 16(3):155–166. https://doi.org/10.1038/s41584-020-0372-xCrossRef

26.

Goyal M (2020) SLE patients are not immune to COVID-19: importance of sending the right message across. Ann Rheum Dis. https://doi.org/10.1136/annrheumdis-2020-217658CrossRef

27.

Pinto AJ, Dunstan DW, Owen N, Bonfa E, Gualano B (2020) Combating physical inactivity during the COVID-19 pandemic. Nat Rev Rheumatol 16(7):347–348. https://doi.org/10.1038/s41584-020-0427-zCrossRef

Title: #Covid4Rheum: an analytical twitter study in the time of the COVID-19 pandemic
Authors: Nikolas Ruffer
Johannes Knitza
Martin Krusche
Publication date: 01-12-2020
Publisher: Springer Berlin Heidelberg
Keyword: COVID-19
Published in: Rheumatology International / Issue 12/2020
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI: https://doi.org/10.1007/s00296-020-04710-5

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

#Covid4Rheum: an analytical twitter study in the time of the COVID-19 pandemic

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 12/2020

Comparing quality and readability of online English language information to patient use and perspectives for common rheumatologic conditions

Kawasaki-like disease in children with COVID-19

Adrenocorticotropic hormone: an effective “natural” biologic therapy for acute gout?

Subclinical atherosclerosis in systemic sclerosis and rheumatoid arthritis: a comparative matched-cohort study

Use of rituximab and the risk of adverse clinical outcomes in COVID-19 patients with systemic rheumatic disease

Correction to: Osteoporosis in patients with rheumatoid arthritis: trends in the German National Database 2007–2017

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page